Editorial & Opinion
Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019.
| العنوان: | Chemotherapy directly followed by poly(ADP-ribose) polymerase inhibition as an alternative to surgery in patients with BRCA-mutated ovarian cancer: a potential management strategy in the era of coronavirus disease 2019. |
|---|---|
| المؤلفون: | Vetter MH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, 320 W 10 Ave., M210 Starling Loving Hall, Columbus, OH 43210. Electronic address: monica.vetter@osumc.edu., Smrz SA; Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH., Copeland LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH., Cohn DE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH. |
| المصدر: | American journal of obstetrics and gynecology [Am J Obstet Gynecol] 2020 Sep; Vol. 223 (3), pp. 469-470. Date of Electronic Publication: 2020 May 23. |
| نوع المنشور: | Letter |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 0370476 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6868 (Electronic) Linking ISSN: 00029378 NLM ISO Abbreviation: Am J Obstet Gynecol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: <2005->: New York : Elsevier Original Publication: St. Louis. |
| مواضيع طبية MeSH: | Betacoronavirus* , Genes, BRCA1* , Genes, BRCA2* , Mutation*, Antineoplastic Agents/*therapeutic use , Carcinoma, Ovarian Epithelial/*drug therapy , Coronavirus Infections/*epidemiology , Ovarian Neoplasms/*drug therapy , Pneumonia, Viral/*epidemiology , Poly(ADP-ribose) Polymerase Inhibitors/*therapeutic use, COVID-19 ; Carcinoma, Ovarian Epithelial/genetics ; Female ; Humans ; Ovarian Neoplasms/genetics ; Pandemics ; SARS-CoV-2 |
| References: | Eur J Cancer. 2016 May;59:22-33. (PMID: 26998845) N Engl J Med. 2018 Dec 27;379(26):2495-2505. (PMID: 30345884) Gynecol Oncol. 2020 Aug;158(2):236-243. (PMID: 32532460) JAMA Oncol. 2017 Dec 1;3(12):1722-1728. (PMID: 28241198) Lancet Oncol. 2020 Mar;21(3):335-337. (PMID: 32066541) |
| المشرفين على المادة: | 0 (Antineoplastic Agents) 0 (Poly(ADP-ribose) Polymerase Inhibitors) |
| تواريخ الأحداث: | Date Created: 20200527 Date Completed: 20200915 Latest Revision: 20240819 |
| رمز التحديث: | 20240819 |
| مُعرف محوري في PubMed: | PMC7255324 |
| DOI: | 10.1016/j.ajog.2020.05.037 |
| PMID: | 32454030 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1097-6868 |
|---|---|
| DOI: | 10.1016/j.ajog.2020.05.037 |